Teva reaches $4.25B deal to settle opioid lawsuits | The Hill
Teva lied about opioid role, New York says | Reuters
Teva, Allergan enter into $58m opioid settlement with San Francisco
Teva, with a $4.25B opioid settlement in hand, eyes return to growth by 2027 | Fierce Pharma
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva Pharmaceuticals, NY reach opioid lawsuit settlements worth $523M - Top Class Actions
Teva Pharmaceuticals - Wikipedia
Teva settles with Oklahoma for $85 million in opioid case | PBS News Weekend
Teva to pay $54M to settle whistleblower lawsuit - Philadelphia Business Journal
Teva agrees to $4.35B settlement to end opioid lawsuits - Top Class Actions
TEVA Stock Surges 24% as Teva Pharmaceuticals Settles Lawsuits | InvestorPlace
Teva to Pay $512 Million to Settle Suit Over Delay of Sleep Disorder Drug - The New York Times
Teva proposes settlement in US opioid lawsuits | Israel National News - Arutz Sheva
Teva Pharmaceuticals found liable for role in New York opioid epidemic - UPI.com
Teva Posts 2021 Earnings and Puts Opioid Litigation in Rearview Mirror – PharmaLive
Pharmaceutical Company Reaches Settlement With Oklahoma In Opioid Case : NPR
Teva reaches proposed $4.35 bln settlement of U.S. opioid lawsuits | Reuters
Teva Agrees to a $420 Million Shareholder Settlement Over Drug Pricing
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
Israeli Teva reaches proposed $4.35 bln settlement of US opioid lawsuits - The Jerusalem Post
Teva to pay $523 mln to New York as it looks to move past opioid lawsuits | Reuters
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Price-fixing lawsuit deals another blow to already fragile Teva, experts say | The Times of Israel
Teva, with a $4.25B opioid settlement in hand, eyes return to growth by 2027 | Fierce Pharma
Teva Pharmaceuticals will pay $420 million in a federal case
